A Novel Dimeric Dipeptide Mimetic of the Nerve Growth Factor Exhibits Pharmacological Effects upon Systemic Administration and Has No Side Effects Accompanying the Neurotrophin Treatment

T. A. Gudasheva; P. Yu. Povarnina; T. A. Antipova; S. B. Seredenin

doi:10.4236/nm.2014.52013

journal article Open Access Jan 01, 2014

A Novel Dimeric Dipeptide Mimetic of the Nerve Growth Factor Exhibits Pharmacological Effects upon Systemic Administration and Has No Side Effects Accompanying the Neurotrophin Treatment

T. A. Gudasheva P. Yu. Povarnina T. A. Antipova S. B. Seredenin

Neuroscience and Medicine Vol. 05 No. 02 pp. 101-108 · Scientific Research Publishing, Inc.

View at Publisher Save 10.4236/nm.2014.52013

Topics

No keywords indexed for this article. Browse by subject →

References

37

[1]

10.1186/1479-5876-10-239

[2]

10.1002/(sici)1097-4547(19970401)48:1<1::aid-jnr1>3.0.co;2-k

[3]

10.1042/bst0340612

[4]

10.1172/jci41356

[5]

10.1523/jneurosci.1508-04.2004

[6]

10.1038/cddis.2012.80

[7]

10.1134/s160767291005011x

[8]

Seredenin, S.B. and Gudasheva, T.A. (2011) Dipeptide Mimetics of NGF and BDNF Neurotrophins. US Patent, Application No. US 2011/0312895 A1.

[9]

10.1098/rstb.2006.1894

[10]

10.1016/j.lfs.2004.01.007

[11]

10.1007/s10517-011-1202-6

[12]

Gudasheva, T., Antipova, T., Povarnina, P. and Seredenin, S. (2013) NGF Loop 4 Dimeric Dipeptide Mimetic Active on Animal Models of Parkinson’s, Alzheimer’s Diseases and Stroke. Proceedings of the 23rd American and the 6th International Peptide Symposium, Big Island, 22-27 June 2013, 194-195. 10.17952/23aps.2013.194

[13]

10.1016/s0304-3940(99)00463-2

[14]

10.1016/j.neulet.2005.12.042

[15]

10.1007/s10517-008-0065-y

[16]

10.1007/s10517-011-1417-6

[17]

10.1073/pnas.89.2.648

[18]

10.1016/s0169-328x(97)00372-0

[19]

Gusev, E.I. and Skvortsova, V.I. (2001) Brain Ischemia. Medicine, Moscow.

[20]

10.1007/s10072-011-0512-9

[21]

Shigeno, T., Mima, T., Takakura, K., Graham, D., Kato, G., Hashimoto, Y. and Furukawa, S. (1991) Amelioration of Delayed Neuronal Death in the Hippocampus by Nerve Growth Factor. The Journal of Neuroscience, 11, 2914-2919. 10.1523/jneurosci.11-09-02914.1991

[22]

10.3109/10717544.2011.557785

[23]

10.1007/s10517-011-1161-y

[24]

10.1007/s10517-011-1388-7

[25]

10.1016/s0376-6357(98)00022-9

[26]

Povarnina, P.Y., Gudasheva, T.A., Vorontsova, O.N., Nikolaev, S.V., Antipova, T.A., Ostrovskaia, R.U. and Seredenin, S.B. (2012) Neuroprotective Effects of a Dipeptide Mimetic of the GK-2 Nerve Growth Factor in Model of Permanent Common Carotid Artery Occlusion in Rats. Eksperimental’naia i klinicheskaia farmakologiia, 75, 15-20.

[27]

Avrushchenko, M.S., Zarzhetsky, Y.V., Moroz, V.V., Ostrova, I.V., Gudasheva, T.A. and Seredenin, S.B. (2012) Effect of Nerve Growth Factor Mimetic GK-2 on Brain Structural and Functional State in the Early Postresuccination Period. General Reanimatology, 8, 19-23. 10.15360/1813-9779-2012-5-19

[28]

Cattaneo, A., Capsoni, S. and Paoletti, F. (2008) Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer’s Disease. Journal of Alzheimer’s Disease, 15, 255-283. 10.3233/jad-2008-15210

[29]

10.1016/j.neulet.2009.02.027

[30]

Koliatsos, V.E., Nauta, H.J., Clatterbuck, R.E., Holtzman, D.M., Mobley, W.C. and Price, D.L. (1990) Mouse Nerve Growth Factor Prevents Degeneration of Axotomized Basal Forebrain Cholinergic Neurons in the Monkey. The Journal of Neuroscience, 10, 3801-3813. 10.1523/jneurosci.10-12-03801.1990

[31]

10.1073/pnas.96.19.10893

[32]

10.1006/exnr.1995.1100

[33]

Povarnina, P.Y., Vorontsova, O.N., Gudasheva, T.A., Ostrovskaya, R.U. and Seredenin, S.B. (2013) Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer’s Disease. Acta Naturae, 5, 84-91. 10.32607/20758251-2013-5-3-84-91

[34]

10.1073/pnas.90.12.5781

[35]

10.2337/diabetes.50.8.1755

[36]

10.2337/diabetes.50.2007.s25

[37]

10.1016/j.jpain.2005.08.003

Metrics

15

Citations

37

References

Details

Published: Jan 01, 2014
Vol/Issue: 05(02)
Pages: 101-108
License: View

Authors

Cite This Article

T. A. Gudasheva, P. Yu. Povarnina, T. A. Antipova, et al. (2014). A Novel Dimeric Dipeptide Mimetic of the Nerve Growth Factor Exhibits Pharmacological Effects upon Systemic Administration and Has No Side Effects Accompanying the Neurotrophin Treatment. Neuroscience and Medicine, 05(02), 101-108. https://doi.org/10.4236/nm.2014.52013

A Novel Dimeric Dipeptide Mimetic of the Nerve Growth Factor Exhibits Pharmacological Effects upon Systemic Administration and Has No Side Effects Accompanying the Neurotrophin Treatment

You May Also Like